Transchem Ltd

Transchem Other Announcement

Transchem's monitoring agency reports no deviation in warrant proceeds utilisation for the quarter ended September 2026. No material facts were flagged.

Transchem Q2 FY27 Results: Net Profit ₹2 Cr, Up 185.7% YoY

Transchem's board approved unaudited standalone and consolidated Q2 and H1 FY27 results on November 4, 2026. The statement shows quarterly total income of ₹396.28 lakh and net profit of ₹202.65 lakh.

Key figure

Net profit ₹2 Cr · +185.7% YoY

Transchem Board Meeting Date

Transchem Ltd intimated BSE that its Board meeting is scheduled for November 4, 2026 to consider un-audited Q2/H1 results. The trading window for designated persons is closed from October 1, 2026.

Transchem Other Announcement

Transchem Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The submission includes minor composition updates to the company's promoter group.

Transchem Annual General Meeting

Transchem Limited submitted the minutes of its 49th Annual General Meeting held on September 05, 2026. Shareholders approved audited financial statements and the re-appointment of Director Mahesh Suresh Rananavre.

Transchem Annual General Meeting

Transchem Limited held its 49th Annual General Meeting on September 05, 2026. Members considered agenda items, including financial statement adoption and related party transaction approvals.

Transchem Merger & Restructuring Worth ₹25.91 Cr

Transchem Limited has executed a Share Purchase Agreement to acquire 100% of Greshma Shares and Stocks Limited for ₹25.91 Crore. The acquired entity becomes a wholly-owned subsidiary.

Value

₹25.91 Cr

Transchem Other Announcement

Transchem Limited has amended its 'Code of Conduct for Prevention of Insider Trading' in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Transchem Q1 FY27 Results: Net Profit ₹3.4 Cr, Up 240.0% YoY

Transchem Ltd reported net profit of ₹3.4 Cr (+240.0% YoY) for Q1 FY27.

Key figure

Net profit ₹3.4 Cr · +240.0% YoY

Transchem Board Meeting Date

Transchem Ltd scheduled a board meeting for August 10, 2026. The meeting aims to consider and approve the June 30, 2026, un-audited financial results.

Transchem Annual General Meeting

Transchem Limited has issued a notice for its 49th Annual General Meeting scheduled for September 5, 2026. Key agenda items include adopting financial statements and approving a related party transaction.

Value

₹0.05 Cr

Transchem Other Announcement

Transchem Limited is dispatching notices for its 49th Annual General Meeting scheduled for September 05, 2026. The communication provides web-links for shareholders to access the Annual Report.

Transchem Annual Report

Transchem Limited has submitted its 49th Annual Report for FY 2025-26. The Annual General Meeting is scheduled for September 05, 2026, via video conferencing.

Transchem Other Announcement

Transchem Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026, noting promoter group changes following an internal entity amalgamation.

Transchem Fund Raise

Transchem Limited allotted 1,20,00,000 warrants to Pishu V. Chainani via a preferential issue. These warrants are convertible into equity shares within 18 months.

Execution

18 months

Transchem Fund Raise of ₹461.2 Cr

Transchem Limited allotted 6.15 crore warrants on a preferential basis, raising ₹461.25 Crore. Warrants are convertible into equity within 18 months, strengthening the company's capital base.

Value

₹461.2 Cr

Execution

18 months

Transchem Other Announcement

Transchem Limited filed its Annual Secretarial Compliance Report for FY2026. A minor ₹0.01 Crore fine was noted for a marginal delay in board meeting intimation.

Value

₹0.01 Cr

Transchem Fund Raise of ₹61.5 Cr

Transchem Limited received BSE in-principle approval for a Rs. 61.50 Crore preferential warrant issue. The company will now proceed with consummating the capital raise.

Value

₹61.50 Cr

Transchem Fund Raise of ₹115 Cr

Transchem Limited clarified its ₹115 Crore preferential warrant issue objects for general corporate purposes. Funds will also support strategic acquisitions in the financial services sector.

Value

₹115.0 Cr

Execution

6–18 months